GoodRx Holdings Inc(GDRX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:29 AM ET (Korea 9/11 20:29)
Full metrics table
| Index | - | P/E | 71.13 | EPS (ttm) | 0.05 | Insider Own | 74.13% | Shs Outstand | 106.2M | Perf Week | -2.9% |
| Market Cap | 1.14B | Forward P/E | 9.41 | EPS next Y | 17.05% | Insider Trans | -1.08% | Shs Float | 88.3M | Perf Month | -11.84% |
| Enterprise Value | 1.39B | PEG | 1.7 | EPS next Q | 0.08 | Inst Own | 16.04% | Short Float | 5.77% | Perf Quarter | 30.86% |
| Income | 0.02B | P/S | 1.46 | EPS this Y | -13.09% | Inst Trans | 0.18% | Short Ratio | 3.67 | Perf Half Y | 48.89% |
| Sales | 0.79B | P/B | 1.76 | EPS next 5Y | 5.52% | ROA | 0.89% | Short Interest | 5.09M | Perf YTD | 23.62% |
| Book/sh | 1.9 | P/C | 3.86 | EPS past 3/5Y | - | ROE | 2.52% | 52W High | -42.34% ($5.81) | Perf Year | -18.69% |
| Cash/sh | 0.87 | P/FCF | 5.8 | Sales past 3/5Y | 1.3% 7.67% | ROIC | 1.38% | 52W Low | 89.27% ($1.77) | Perf 3Y | -45.79% |
| Dividend Est. | - | EV/EBITDA | 7.58 | EPS Y/Y TTM | -48.77% | Gross Margin | 79.54% | Volatility(W/M) | 3.67% 3.94% | Perf 5Y | -92.1% |
| Dividend TTM | - | EV/Sales | 1.76 | Sales Y/Y TTM | -1.83% | Oper. Margin | 12% | ATR (14) | 0.14 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.38 | EPS Q/Q | -31.94% | Profit Margin | 2.07% | RSI (14) | 45.38 | Recom | 2.62 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.38 | Sales Q/Q | -1.31% | SMA20 | -5.09% ($3.53) | Beta | 1.69 | Target Price | $4.03 |
| Payout | - | Debt/Eq | 0.83 | Earnings | 2026/8/5 | SMA50 | 1.02% ($3.32) | Rel Volume | 0.7 | Prev Close | $3.34 |
| Employees | 697 | LT Debt/Eq | 0.82 | EPS/Sales Surpr. | 0.38% 3.72% | SMA200 | 23.91% ($2.7) | Avg Volume(3M) | 1.39M | Price | $3.35 |
| IPO | 2020/9/23 | Option/Short | Yes/Yes | Trades | 5740 | Volume | 971,679 | Change | 0.3% |
Company
GDRX is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💊 GoodRx Holdings (GDRX) is a U.S.-based healthcare information services company that operates a platform for comparing prescription drug prices and providing discounts. It connects consumers so they can compare prescription prices across pharmacies and obtain discount coupons to lower their medication costs, while expanding its business through marketing solutions for pharmaceutical manufacturers and subscription services.
Over the past 1 year, roughly in the middle
42% below its 1-year high.
GDRX makes money exceptionally well
12% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -13.1% this year.
Tap to view numbers
The stock looks undervalued
Trading at 71.1 times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -45.8% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 16.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
DSMC 0.00%
SQLV 0.00%
SFLO 0.00%
HAPS 0.00%
EES 0.00%It ranks #4 in the industry
Based on market cap of $1B.
GDRX $1B PER 71.1
VEEV $42B PER 42.9
BTSG $11B PER 43.2
TEM $11B PER -
FAQ
What kind of company is GDRX?
GDRX belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of GDRX?
The market cap of GDRX is approximately $1.1B, ranking 2,535 within its sector.
What is the P/E ratio of GDRX?
GDRX has a P/E ratio of approximately 71.1x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for GDRX?
GDRX has recorded a 52-week high of $5.81 and a low of $1.77.
